Molecule

Iopamidol

Radiographic Contrast Agent

Available on requestContrast media and diagnostics

Presentations: 29
Brands: 5
Manufacturers: 1
Available from stock: 0

Iopamidol is a radiographic contrast agent. It is available as injection for intravascular and intrathecal use. MedsAcross supplies Iopamidol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class: Radiographic Contrast Agent, X-Ray Contrast Activity
ATC classification: V08AB04 Iopamidol · Iodinated contrast, subgroup V08AB
US FDA first approval: 31 December 1985
EU status: Not recorded
Orphan designation: Not recorded
WHO essential medicine: Not recorded
India (CDSCO): Not yet confirmed against CDSCO approval lists
Routes: Intravascular, Intrathecal
Dosage forms: Injection
Identifiers: UNII JR13W81H44RxCUI 5966CAS 60166-93-0DrugBank DB08947Q424788

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

ISOVUE is a radiographic contrast agent indicated for: Intra-arterial Procedures †. Cerebral arteriography in adults Peripheral arteriography in adults Selective visceral arteriography and aortography in adults Coronary arteriography and cardiac ventriculography in adults Angiocardiography in pediatric patients Intravenous Procedures †. Excretory urography in adults and pediatric patients Computed tomography (CT) of head and body in adults and pediatric patients Peripheral venography in adults Oral Procedures †. CT of the abdomen and pelvis to delineate the gastrointestinal tract in adults and pediatric patients † Specific concentrations are recommended for each type of imaging procedure.

Source: US FDA prescribing information

How it works

The iodine atoms in iopamidol provide attenuation of X-rays in direct proportion to the concentration of iopamidol. Since concentration changes over time, iopamidol provides time-dependent image contrast, which may assist in visualizing body structures. In imaging of the body, iopamidol diffuses from the vessels into the extravascular space. In normal brain with an intact blood-brain barrier, iopamidol does not diffuse into the extravascular space. In patients with a disrupted blood-brain barrier, iopamidol accumulates in the extravascular space in the region of disruption.

Source: US FDA prescribing information

Dosing overview

Individualize the volume and concentration according to the specific dosing tables accounting for factors such as age, body weight, size of the vessel, and the rate of blood flow within the vessel. See full prescribing information for important dosage and administration information and dilution instructions.

Source: US FDA prescribing information

Contraindications

None. None

Source: US FDA prescribing information

Warnings and precautions

Boxed warning (risks associated with intrathecal administration): Intrathecal administration of ISOVUE, even if inadvertent, can cause death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. ISOVUE is for intra-arterial, intravenous, or oral use only. Hypersensitivity Reactions: Life-threatening or fatal reactions can occur. Always have emergency resuscitation equipment and trained personnel available. Acute Kidney Injury: Acute injury including renal failure can occur. Use the lowest dose and maintain adequate hydration to minimize risk. Cardiovascular Adverse Reactions: Hemodynamic disturbances including shock and cardiac arrest may occur during or after ISOVUE administration.

Source: US FDA prescribing information

Side effects

The following adverse reactions are described in greater detail elsewhere in the labeling: Risks Associated with Intrathecal Administration Hypersensitivity Reactions Acute Kidney Injury Cardiovascular Adverse Reactions Thromboembolic Events Extravasation and Injection Site Reactions Thyroid Dysfunction in Pediatric Patients 0 to 3 Years of Age Severe Cutaneous Adverse Reactions Most common adverse reactions (incidence >1%) from intra-arterial or intravenous use are pain, hot flashes, burning sensation, nausea, and warmth.

Source: US FDA prescribing information

Storage

Store at 20°C to 25°C (68°F to 77°F). Protect from light.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

29 presentations of Iopamidol, sorted by availability.

Medicine	Manufacturer	Register	Availability
Iopamidol 408 mg/mL injectionIntrathecalGeneric name	—	US FDA	Available on request
Iopamidol 18360 mg/30 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 20400 mg/50 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 25500 mg/50 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 30600 mg/50 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 37750 mg/50 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 4080 mg/10 mL injectionIntrathecalGeneric name	—	US FDA	Available on request
Iopamidol 56625 mg/75 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 612 mg/mL injectionIntrathecalGeneric name	—	US FDA	Available on request
Iopamidol 61200 mg/100 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 75500 mg/100 mL injectionIntravascularGeneric name	—	US FDA	Available on request
Iopamidol 8160 mg/20 mL injectionIntrathecalGeneric name	—	US FDA	Available on request
Iopamidol 9180 mg/15 mL injectionIntrathecalGeneric name	—	US FDA	Available on request
Isovue 200 81600 mg/200 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 250 51000 mg/100 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 122400 mg/200 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 18360 mg/30 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 30600 mg/50 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 306000 mg/500 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 61200 mg/100 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 300 91800 mg/150 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 113250 mg/150 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 151000 mg/200 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 37750 mg/50 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 377500 mg/500 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 75500 mg/100 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue 370 94375 mg/125 mL injectionIntravascular	Bracco Diagnostics	US FDA	Available on request
Isovue-m 4080 mg/10 mL injectionIntrathecal	Bracco Diagnostics	US FDA	Available on request
Isovue-m 9180 mg/15 mL injectionIntrathecal	Bracco Diagnostics	US FDA	Available on request

Brands by market

5 brand names across 1 markets.

Brand names by country

United States

Isovue 200 Isovue 250 Isovue 300 Isovue 370 Isovue-m

Manufacturers

Bracco Diagnostics16 presentations

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

Register	Status	Source
US FDA	First approved 31 December 1985	Drugs@FDA
EU (EMA)	Not recorded	—
India (CDSCO)	Not yet confirmed against CDSCO approval lists	—
United States	Registered	US FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Iopamidol available for export from India?

Yes, on request. MedsAcross lists 29 presentations of Iopamidol and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Iopamidol have?

The catalogue lists 5 brand names for Iopamidol, including Isovue 200, Isovue 250, Isovue 300, Isovue 370, Isovue-m.

Is Iopamidol approved by the US FDA?

Yes. The US FDA first approved Iopamidol on 31 December 1985, according to Drugs@FDA.

Does Iopamidol need cold chain shipping?

No listed presentation of Iopamidol is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Iopamidol in?

Iopamidol is classified under ATC code V08AB04 (Iopamidol).

References

ISOVUE 200 prescribing information (Bracco Diagnostics). U.S. National Library of Medicine, DailyMed. Retrieved 10 March 2026

Request Iopamidol for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.

Request a quote Read the import guides